Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aura Biosciences, Inc. (AURA) had Stock-Based Compensation of $11.72M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-86.92M |
|
-- |
|
-- |
|
$96.12M |
|
$-96.12M |
|
$9.31M |
|
$-86.81M |
|
$-86.81M |
|
$-86.92M |
|
$-86.92M |
|
$-86.92M |
|
$-86.92M |
|
$-96.12M |
|
$-94.89M |
|
49.65M |
|
49.65M |
|
$-1.75 |
|
$-1.75 |
|
| Balance Sheet Financials | |
$160.62M |
|
$3.21M |
|
$21.88M |
|
$182.50M |
|
$14.91M |
|
-- |
|
$15.62M |
|
$30.53M |
|
$151.97M |
|
$151.97M |
|
$151.97M |
|
50.00M |
|
| Cash Flow Statement Financials | |
$-79.81M |
|
$68.82M |
|
$1.59M |
|
$41.85M |
|
$32.46M |
|
$-9.39M |
|
|
Stock-Based Compensation |
$11.72M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.19% |
|
-57.19% |
|
-47.63% |
|
-57.19% |
|
$3.04 |
|
$-1.63 |
|
$-1.61 |
|